Phase II trial of combined modality therapy with myeloid growth factor support in patients with locally advanced non-small cell lung cancer

Rogerio Lilenbaum, Michael Samuels, Michele Taffaro-Neskey, Mike Cusnir, Joseph Pizzolato, Arnold Blaustein

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of combined modality therapy with myeloid growth factor support in patients with locally advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences